BioMarin Pharmaceutical Inc.
Income Statement
| Line Item | FY2009 | FY2008 |
|---|---|---|
| Revenue | $324.7M | $296.5M |
| Cost of Revenue | $65.9M | $52.5M |
| Gross Profit | $258.7M | $244.0M |
| Gross Margin | 79.7% | 82.3% |
| Operating Expenses | ||
| Research & Development | $115.1M | $93.3M |
| SG&A Expense | $124.3M | $106.6M |
| Operating Income | $16.4M | $39.8M |
| Operating Margin | 5.1% | 13.4% |
| Interest Expense | $14.1M | $16.4M |
| Pretax Income | $566.0K | $33.4M |
| Income Tax Expense | $1.1M | $2.6M |
| Net Income | $-488.0K | $30.8M |
| Net Margin | -0.2% | 10.4% |
| EPS (Basic) | $0.00 | $0.31 |
| EPS (Diluted) | $0.00 | $0.29 |
| Shares Outstanding (Basic) | 100.3M | 99.0M |
| Shares Outstanding (Diluted) | 100.3M | 103.6M |
| Dividends Per Share | — | — |